Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Linagliptin

Linagliptin Process Related & Degradation Impurities / Linagliptin Related Compounds / Reference Standards

Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage type 2 diabetes mellitus. It helps regulate blood sugar levels by increasing incretin hormones, which enhance insulin secretion and suppress glucagon release. Linagliptin is typically used as monotherapy or in combination with other antidiabetic agents.

Explore a comprehensive range of Linagliptin-related compounds and reference standards essential for pharmaceutical research. These materials support various stages of drug development, including product formulation, ANDA submissions, and manufacturing. They are critical for conducting quality assessments, stability studies, and genotoxicity evaluations of Linagliptin and its related products.

SynThink is a trusted provider of high-quality Linagliptin impurities, including: Degradation impurities; Genotoxic impurities; Process-related impurities; EP/USP-compliant reference standards; Nitrosamine impurities.

All compounds are rigorously characterized and re-tested at regular intervals to ensure consistency and compliance. Each product is supplied with a detailed Certificate of Analysis (CoA) and comprehensive analytical data, meeting global regulatory standards.

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: NA

Mol F.

: C25H26N10O4

Mol W.

: 530.54

Cat No.

: SA49953

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 2983074-55-9

Mol F.

: C26H29N9O3

Mol W.

: 515.6

Cat No.

: SA49918

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: NA

Mol F.

: C51H55N17O5

Mol W.

: 986.09

Cat No.

: SA49954

Registration

Register to add the product to RFQ list

Already have an account?